Hamostaseologie 2010; 30(S 01): S164-S167
DOI: 10.1055/s-0037-1619105
Original article
Schattauer GmbH

Comparative evaluation of PAR1, GPIb-IX-V, and integrin αIIbβ3 levels in cord and adult platelets

Vergleichende Bestimmung des Gehalts von PAR1, GPIb-IX-V, and Integrin αIIbβ3 in Nabelschnur- und Erwachsenen-Thrombozyten
A. Schlagenhauf
1   Department of Paediatrics, Medical University of Graz, Austria
,
S. Schweintzger
1   Department of Paediatrics, Medical University of Graz, Austria
,
R. Birner-Grünberger
2   Center for Medical Research, Medical University Graz, Austria
,
B. Leschnik
1   Department of Paediatrics, Medical University of Graz, Austria
,
W. Muntean
1   Department of Paediatrics, Medical University of Graz, Austria
› Author Affiliations
Further Information

Publication History

Publication Date:
23 December 2017 (online)

Summary

Background: Newborn platelets show hyposensitivity in vitro to many important agonists. However, sensitivity of platelets to these agonists is crucial for a functional clot formation. Nevertheless newborns have an excellent hemostasis. Hence, we examined levels of PAR1 thrombin receptor, GPIb-IX-V (CD42b), and Integrin αIIbβ3 in newborn and adult platelets using Western blot analysis.Materials, methods: Platelets of adult and cord blood were isolated, washed, and lysed. Protein samples were separated by SDS-PAGE and blotted on nitrocellulose membranes. Receptors were visualized using immunodetection and evaluated densitometrically. Statistical analysis was performed using SPSS 16.0. Results: We found significantly lower levels of PAR1-receptors and higher levels of CD42b in newborn platelets as compared to adult platelets. Levels of Integrin αIIbβ3 in newborn platelets were comparable to adult platelets. Conclusion: A lower content of PAR1-receptors explains very well the hyposensitivity of cord platelets to thrombin. Higher levels of CD42b may additionally support the effect of larger more adhesive multimeric vWF in newborn plasma.

Zusammenfassung

Hintergrund: Neugeborenen-Thrombozyten weisen in vitro eine Hyposensitivität gegenüber wichtigen Agonisten auf, deren Reaktivität jedoch notwendig ist für eine funktionierende Hämostase. Dennoch haben Neugeborene keine Blutungsneigung. Daher untersuchten wir mittels Western-Blots Neugeborenen- und Erwachsenen-Thrombozyten auf deren Gehalt an PAR1-Thrombinrezeptoren, GPIb-IX-V (CD42b) und Integrin αIIbβ3. Material, Methoden: Thrombozyten von Erwachsenen- und Nabelschnurblut wurden isoliert, gewaschen und lysiert. Die Proteinproben wurden mittels SDS-PAGE aufgetrennt, auf Nitrozellulose-Membranen geblottet, und die Rezeptoren mittels Immunodetektion sichtbar gemacht. Die Banden wurden densitometrisch ausgewertet. Statistische Analysen wurden mit SPSS 16.0 durchgeführt. Ergebnisse: Ein signifikant niedrigerer Gehalt an PAR1-Rezeptoren und ein signifikant höherer Gehalt an CD42b in Neugeborenen-Thrombozyten konnte festgestellt werden. Der Gehalt von Integrin αIIbβ3 war vergleichbar mit Erwachsenen. Schlussfolgerung: Eine geringere Menge an PAR1-Rezeptoren liefert eine gute Erklärung für die Hyposensitivität von Neugeborenen-Thrombozyten gegenüber Thrombin.

 
  • References

  • 1 Israels SJ, Daniels M, McMillan EM. Deficient collagen-induced activation in the newborn platelet. Pediatr Res 1990; 27: 337-343.
  • 2 Mull MM, Hathaway WE. Altered platelet function in newborns. Pediatr Res 1970; 04: 229-237.
  • 3 Rajasekhar D, Kestin AS, Bednarek FJ. et al. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994; 72: 957-963.
  • 4 Weinstein MJ, Blanchard R, Moake JL. et al. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol 1989; 72: 68-72.
  • 5 Rehak T, Cvirn G, Gallistl S. et al. Increased shear stress- and ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma. Thromb Haemost 2004; 92: 682-687.
  • 6 Simak J, Holada K, Janota J, Stranak Z. Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets. Pediatr Res 1999; 46: 445-449.
  • 7 Wasiluk A. The expression of vWF receptor on newborn platelets. Med Sci Monit 2005; 11: R545-R548.
  • 8 Hezard N, Potron G, Schlegel N. et al. Unexpected persistence of platelet hyporeactivity beyond the neonatal period: a flow cytometric study in neonates, infants and older children. Thromb Haemost 2003; 90: 116-123.
  • 9 Wasiluk A. Membrane-activated form of glycoproteins IIb/IIIa complex on newborn platelets. Fetal Diagn Ther 2006; 21: 177-180.
  • 10 Corby DG, O’Barr TP. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine. Dev Pharmacol Ther 1981; 02: 215-225.
  • 11 Grosshaupt B, Muntean W, Sedlmayr P. Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur J Pediatr 1997; 156: 944-948.
  • 12 Nicolini U, Guarneri D, Gianotti GA. et al. Maternal and fetal platelet activation in normal pregnancy. Obstet Gynecol 1994; 83: 65-69.
  • 13 Irken G, Uysal K, Olgun N. et al. Platelet activation during the early neonatal period. Biol Neonate 1998; 73: 166-171.
  • 14 Bernhard H, Rosenkranz A, Petritsch M. et al. Phospholipid content, expression and support of thrombin generation of neonatal platelets. Acta Paediatr 2009; 98: 251-255.
  • 15 Cvirn G, Kutschera J, Wagner T. et al. Collagen/endogenous thrombin-induced platelet aggregation in cord versus adult whole blood. Neonatology 2008; 95: 187-192.
  • 16 Israels SJ, Cheang T, Roberston C. et al. Impaired signal transduction in neonatal platelets. Pediatr Res 1999; 45: 687-691.